Development of an autophagy activator from class iii pi3k complexes, tat-becn1 peptide: mechanisms and applications

HIGHLIGHTS

• who: September et al. from the Weizmann Institute of Science, Israel (CSIC), Spain Institute of Future Agriculture, Northwest AandF University, Yangling, China have published the research work: Development of an autophagy activator from Class III PI3K complexes, Tat-BECN1 peptide: Mechanisms and applications, in the Journal: (JOURNAL)

SUMMARY

Autophagy, the evolutionarily conserved pathway to target unwanted or damaged cellular contents to lysosomes for degradation, is linked to numerous human diseases (Levine and Kroemer, 2019; Mizushima and Levine, 2020) and considered a therapeutic target (Galluzzi et_al, 2017). Autophagy can be activated by many approaches . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.